Cargando…
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia
SARS-CoV-2 vaccines have been carefully developed and significantly alleviate the global pandemic. However, a rare but severe complication after vaccination of adenoviral vector vaccines has attracted worldwide attention. It is characterized by thrombosis at unusual sites (often cerebral or abdomina...
Autores principales: | Liu, Yumei, Shao, Zonghong, Wang, Huaquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647389/ https://www.ncbi.nlm.nih.gov/pubmed/34894531 http://dx.doi.org/10.1016/j.thromres.2021.12.002 |
Ejemplares similares
-
SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2021) -
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban
por: Guetl, Katharina, et al.
Publicado: (2021) -
SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Elalamy, Ismail, et al.
Publicado: (2021) -
Case of Suspected SARS-CoV-2 Vaccine-induced Immune Thrombotic Thrombocytopenia: Dilemma for Organ Donation
por: Tiwari, Anand M, et al.
Publicado: (2022) -
Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia
por: Althaus, Karina, et al.
Publicado: (2021)